CYP3A5 CONTRIBUTION TO BUDESONIDE TREATMENT FAILURE IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS.

被引：0
|
作者：
Chevalier, R. [1 ,2 ]
Shakhnovich, V. [1 ,2 ,3 ]
Gaedigk, R. [1 ]
Pirani, K. [1 ]
Noel-MacDonnell, J. [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO USA
[2] Univ Missouri, Kansas City, MO 64110 USA
[3] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-047
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [41] Evidence of significant contribution from CYP3A5 to hepatic drug metabolism
    Huang, WL
    Lin, YS
    McConn, DJ
    Calamia, JC
    Totah, RA
    Isoherranen, N
    Glodowski, M
    Thummel, KE
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) : 1434 - 1445
  • [42] PharmVar GeneFocus: CYP3A5
    Rodriguez-Antona, Cristina
    Savieo, Jessica L.
    Lauschke, Volker M.
    Sangkuhl, Katrin
    Drogemoller, Britt, I
    Wang, Danxin
    Schaik, Ron N. H.
    Gilep, Andrei A.
    Peter, Arul P.
    Boone, Erin C.
    Ramey, Bronwyn E.
    Klein, Teri E.
    Whirl-Carrillo, Michelle
    Pratt, Victoria M.
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1159 - 1171
  • [43] Presentation of Eosinophilic Esophagitis as Failure to Thrive in Young Children
    Dalal, I.
    Zangen, T.
    Shaoul, R.
    Levine, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB166 - AB166
  • [44] Maintenance-treatment of eosinophilic esophagitis with budesonide (BEE-M Trial)
    Straumann, A.
    Conus, S.
    Bussmann, C.
    Degen, L.
    Beglinger, C.
    Simon, H.
    ALLERGY, 2010, 65 : 342 - 343
  • [45] Differential Treatment effects of Budesonide on Eosinophilic Esophagitis (EoE) versus Healthy Fibroblasts
    Hsieh, Lance Y.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB137 - AB137
  • [46] BUDESONIDE ORAL SUSPENSION TREATMENT IMPROVES DYSPHAGIA SYMPTOMS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Hirano, I.
    Collins, M.
    Katzka, D.
    Mukkada, V.
    Falk, G.
    Johnston, D.
    Soteres, D.
    Williams, J.
    Desai, N.
    Lan, L.
    Morey, R.
    Dellon, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S56 - S57
  • [47] Maintenance-Treatment of Eosinophilic Esophagitis with Budesonide (BEE-M Trial)
    Straumann, Alex
    Conus, Sebastien
    Degen, Lukas
    Bussmann, Christian
    Schoepfer, Alain
    Simon, Hans-Uwe
    SWISS MEDICAL WEEKLY, 2010, 140 : 11S - 11S
  • [48] Nutrition Guidelines for Treatment of Children with Eosinophilic Esophagitis
    Henry, Michelle
    PRACTICAL GASTROENTEROLOGY, 2014, 38 (06) : 21 - 30
  • [49] Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
    Lin, YS
    Dowling, ALS
    Quigley, SD
    Farin, FM
    Zhang, J
    Lamba, J
    Schuetz, EG
    Thummel, KE
    MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 162 - 172
  • [50] Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression
    Kolwankar, D
    Ho, H
    Ethell, B
    Vuppalanchi, R
    Marri, SR
    Wrighton, SA
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
12345